Epirubicin is an anthracycline antineoplastic agent widely utilized in chemotherapy for the treatment of breast cancer, ovarian cancer, soft tissue sarcomas, and other malignancies. This cytotoxic drug… Read more




















Epirubicin is an anthracycline antineoplastic agent widely utilized in chemotherapy for the treatment of breast cancer, ovarian cancer, soft tissue sarcomas, and other malignancies. This cytotoxic drug functions by intercalating into DNA and inhibiting topoisomerase II, thereby preventing essential DNA replication and transcription processes in tumor cells. To support the rigorous quality control and regulatory compliance of the drug substance, laboratories rely on a comprehensive selection of Epirubicin related compounds. This collection includes pharmacopeial and non-pharmacopeial impurities, metabolites such as glucuronides, and stable isotope-labelled reference standards. These materials are critical for accurate impurity profiling, method validation, and quantitative analysis, ensuring that analytical procedures can reliably detect and quantify potential degradation products or metabolic byproducts throughout the pharmaceutical development and manufacturing process.